Swiss pharmaceuticals giant Roche Holding S.A. agreed to buy the shares of oncology software company Flatiron Health Inc. that it doesn’t already own for $1.9 billion, increasing its capabilities in cancer medicines.
from WSJ.com: US Business http://ift.tt/2ExlxgM
via IFTTT
No comments:
Post a Comment